AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - Results of two parallel first-in-human phase I studies

A. Omlin, R. J. Jones, R. Van Der Noll, T. Satoh, M. Niwakawa, S. A. Smith, J. Graham, M. Ong, R. D. Finkelman, J. H.M. Schellens, A. Zivi, M. Crespo, R. Riisnaes, D. Nava-Rodrigues, M. D. Malone, C. Dive, R. Sloane, D. Moore, J. J. Alumkal, A. DymondP. A. Dickinson, M. Ranson, G. Clack, J. De Bono, T. Elliott

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - Results of two parallel first-in-human phase I studies'. Together they form a unique fingerprint.

Medicine & Life Sciences